1. Marginal pulmonary function should not preclude lobectomy in selected patients with non–small cell lung cancer 
Matthew D. Taylor, MD, Damien J. LaPar, MSc, MD, James M. Isbell, MD, MSCI, Benjamin D. Kozower, MD, MPH, Christine L. Lau, MD, MBA, David R. Jones, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 147, Issue 2, Pages (February 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
A, Risk-adjusted overall survival curve for American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021 trial or American College of Chest Physicians (ACCP) marginal-pulmonary function test (M-PFIT) criteria. B, Risk-adjusted overall survival curve for ACCP M-PFT criteria.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions